000 | 01249 a2200313 4500 | ||
---|---|---|---|
005 | 20250516025655.0 | ||
264 | 0 | _c20110516 | |
008 | 201105s 0 0 eng d | ||
022 | _a1091-6490 | ||
024 | 7 |
_a10.1073/pnas.1019656108 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHormigo, AdÃlia | |
245 | 0 | 0 |
_aA target for antiangiogenic therapy: vascular endothelium derived from glioblastoma. _h[electronic resource] |
260 |
_bProceedings of the National Academy of Sciences of the United States of America _cMar 2011 |
||
300 |
_a4271-2 p. _bdigital |
||
500 | _aPublication Type: Comment; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
650 | 0 | 4 |
_aCell Transdifferentiation _xdrug effects |
650 | 0 | 4 |
_aEndothelial Cells _xmetabolism |
650 | 0 | 4 |
_aGlioblastoma _xblood supply |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
700 | 1 | _aDing, Bi-Sen | |
700 | 1 | _aRafii, Shahin | |
773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 108 _gno. 11 _gp. 4271-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.1019656108 _zAvailable from publisher's website |
999 |
_c20655719 _d20655719 |